Accordingly, PBC patients with high‐level of gp210 antibody is more likely to occur cirrhosis than patients with low‐level of gp210 antibody and it requires close monitoring serum level of gp210 antibody by the clinicians during treatment. The gene discussed is NUP210; the disease is Cirrhosis.